Back to search
Primary or Secondary Hypogonadism
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Primary or Secondary Hypogonadism trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Primary or Secondary Hypogonadism trials you may qualify forThis is a 52-week open label single arm study + 24-Month long-term safety extension to investigate the effects of XYOSTED, as testosterone replacement therapy,…
CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, i…
DITEST is an oral formulation of native testosterone for the treatment of androgen deficiency in men. The study was a Phase 1 clinical study in hypogonadal men,…
This study is to observe efficacy and safety after T-Gel 1% treatment in delayed puberty adolescents. Subjects who complete this trial may enter a 3 month exten…
Measure and evaluate the level of testosterone in blood, and determine the safety and tolerability following daily applications of testosterone gel. Subjects wh…